{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:24:31Z","timestamp":1790771071648,"version":"4.1.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["AZV NU20-02-00244"],"award-info":[{"award-number":["AZV NU20-02-00244"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["heartrhythmopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm O2"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.hroo.2021.08.007","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T03:03:47Z","timestamp":1639710227000},"page":"796-806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"PB","title":["Management of ventricular arrhythmias in heart failure: Current perspectives"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5625-0071","authenticated-orcid":false,"given":"Petr","family":"Peichl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Rafaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Kautzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hroo.2021.08.007_bib1","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2021.08.007_bib2","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/CIRCULATIONAHA.111.023846","article-title":"Sudden cardiac death caused by coronary heart disease","volume":"125","author":"Myerburg","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.08.007_bib3","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1161\/CIRCEP.113.001034","article-title":"Public health burden of sudden cardiac death in the United States","volume":"7","author":"Stecker","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib4","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.hroo.2021.08.007_bib5","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.jacc.2017.01.047","article-title":"Management of ventricular arrhythmias in patients with advanced heart failure","volume":"69","author":"Santangeli","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib6","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00001573-200005000-00014","article-title":"Molecular aspects of arrhythmias associated with cardiomyopathies","volume":"15","author":"Tomaselli","year":"2000","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib7","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1161\/CIRCULATIONAHA.106.642892","article-title":"Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial","volume":"114","author":"Saxon","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.08.007_bib8","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jacc.2013.04.083","article-title":"Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study","volume":"62","author":"Powell","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(14)61903-6","article-title":"Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE)","volume":"385","author":"Healey","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.hroo.2021.08.007_bib10","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2005.09.016","article-title":"Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial","volume":"46","author":"Carson","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib11","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/ejhf.152","article-title":"Super-responders to cardiac resynchronization therapy remain at risk for ventricular arrhythmias and benefit from defibrillator treatment","volume":"16","author":"van der Heijden","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hroo.2021.08.007_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004875","article-title":"Cardiac resynchronization therapy reduces ventricular arrhythmias in primary but not secondary prophylactic implantable cardioverter defibrillator patients: insight from the Resynchronization in Ambulatory Heart Failure Trial","volume":"10","author":"Sapp","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib13","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/CIRCEP.114.002394","article-title":"Characteristics of ventricular tachycardia ablation in patients with continuous flow left ventricular assist devices","volume":"8","author":"Sacher","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib14","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.hrthm.2017.07.027","article-title":"Predictors of ventricular arrhythmia after left ventricular assist device implantation: a large single-center observational study","volume":"14","author":"Efimova","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.08.007_bib15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2261-13-52","article-title":"\u03b2-Blockers for the prevention of sudden cardiac death in heart failure patients: a meta-analysis of randomized controlled trials","volume":"13","author":"Al-Gobari","year":"2013","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.hroo.2021.08.007_bib16","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2021.08.007_bib17","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2021.08.007_bib18","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJM198908103210629","article-title":"Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction","volume":"321","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2021.08.007_bib19","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1161\/CIRCULATIONAHA.118.038036","article-title":"Quinidine-responsive polymorphic ventricular tachycardia in patients with coronary heart disease","volume":"139","author":"Viskin","year":"2019","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.hroo.2021.08.007_bib20","article-title":"Quinidine in the management of recurrent ventricular arrhythmias: a reappraisal","volume":"S2405-500X","author":"Li","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.295.2.165","article-title":"Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial","volume":"295","author":"Connolly","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.hroo.2021.08.007_bib22","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.hrthm.2016.03.004","article-title":"Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Santangeli","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.08.007_bib23","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/eurheartj\/ehp100","article-title":"Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials","volume":"30","author":"Piccini","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2021.08.007_bib24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1513614","article-title":"Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs","volume":"375","author":"Sapp","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2021.08.007_bib25","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/europace\/eux077","article-title":"Catheter ablation for ventricular tachycardia in patients with cardiac sarcoidosis: a systematic review","volume":"20","author":"Papageorgiou","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2021.08.007_bib26","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.hrthm.2018.11.024","article-title":"Arrhythmias in myocarditis: state of the art","volume":"16","author":"Peretto","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.08.007_bib27","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1016\/j.hrthm.2019.03.014","article-title":"2019 HRS\/EHRA\/APHRS\/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias: executive summary","volume":"17","author":"Cronin","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.08.007_bib28","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/jce.14374","article-title":"Programmed ventricular stimulation in patients with active vs previous arrhythmic myocarditis","volume":"31","author":"Peretto","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib29","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.jacc.2017.10.053","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary","volume":"72","author":"Al-Khatib","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib30","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1161\/01.CIR.101.11.1297","article-title":"Canadian implantable defibrillator study (CIDS)\u00a0: a randomized trial of the implantable cardioverter defibrillator against amiodarone","volume":"101","author":"Connolly","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.08.007_bib31","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJM199711273372202","article-title":"A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias","volume":"337","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2021.08.007_bib32","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.CIR.102.7.748","article-title":"Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH)","volume":"102","author":"Kuck","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.08.007_bib33","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/S0735-1097(01)01597-2","article-title":"Life-threatening ventricular arrhythmias due to transient or correctable causes: high risk for death in follow-up","volume":"38","author":"Wyse","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib34","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.005940","article-title":"Implantable defibrillator therapy in cardiac arrest survivors with a reversible cause","volume":"11","author":"Ladejobi","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib35","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2021.08.007_bib36","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1056\/NEJM199912163412503","article-title":"A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators","volume":"341","author":"Buxton","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2021.08.007_bib37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2021.08.007_bib38","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","article-title":"Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia","volume":"335","author":"Moss","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2021.08.007_bib39","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1093\/eurheartj\/ehaa226","article-title":"Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study","volume":"41","author":"Zabel","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2021.08.007_bib40","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1161\/CIRCULATIONAHA.119.043012","article-title":"Association between use of primary-prevention implantable cardioverter-defibrillators and mortality in patients with heart failure: a prospective propensity score-matched analysis from the Swedish Heart Failure Registry","volume":"140","author":"Schrage","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.08.007_bib41","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"K\u00f8ber","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2021.08.007_bib42","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/heartjnl-2016-310850","article-title":"Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis","volume":"104","author":"Beggs","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.hroo.2021.08.007_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1609758","article-title":"Declining risk of sudden death in heart failure","volume":"377","author":"Shen","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2021.08.007_bib44","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1093\/eurheartj\/ehaa645","article-title":"The PROFID project","volume":"41","author":"Dagres","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2021.08.007_bib45","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCEP.113.001217","article-title":"Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis","volume":"7","author":"Tan","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib46","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.hrthm.2014.02.009","article-title":"Impact of prolonged implantable cardioverter-defibrillator arrhythmia detection times on outcomes: a meta-analysis","volume":"11","author":"Scott","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.08.007_bib47","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJMoa1915932","article-title":"Subcutaneous or transvenous defibrillator therapy","volume":"383","author":"Knops","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2021.08.007_bib48","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jacep.2018.11.011","article-title":"Wearable cardioverter-defibrillator therapy for the prevention of sudden cardiac death: a systematic review and meta-analysis","volume":"5","author":"Masri","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib49","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/jce.14404","article-title":"Impact of wearable cardioverter-defibrillator compliance on outcomes in the VEST trial: as-treated and per-protocol analyses","volume":"31","author":"Olgin","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib50","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1161\/CIRCULATIONAHA.108.810606","article-title":"How to respond to an implantable cardioverter-defibrillator recall","volume":"119","author":"Kirian","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.08.007_bib51","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/01.CIR.79.2.256","article-title":"Sustained bundle branch reentry as a mechanism of clinical tachycardia","volume":"79","author":"Caceres","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.08.007_bib52","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1161\/01.CIR.88.4.1647","article-title":"Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction","volume":"88","author":"Stevenson","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.08.007_bib53","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1161\/01.CIR.88.3.915","article-title":"Slow conduction in the infarcted human heart. \u201cZigzag\u201d course of activation","volume":"88","author":"de Bakker","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.08.007_bib54","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.CIR.0000083725.72693.EA","article-title":"Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia","volume":"108","author":"Hsia","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.08.007_bib55","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1161\/CIRCULATIONAHA.108.788604","article-title":"Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial","volume":"118","author":"Stevenson","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.08.007_bib56","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1161\/CIRCULATIONAHA.111.043216","article-title":"Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia","volume":"125","author":"Ja\u00efs","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.08.007_bib57","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2015.10.026","article-title":"Ablation of stable VTs versus substrate ablation in ischemic cardiomyopathy","volume":"66","author":"Di Biase","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib58","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1161\/CIRCEP.114.002386","article-title":"Scar dechanneling: new method for scar-related left ventricular tachycardia substrate ablation","volume":"8","author":"Berruezo","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib59","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1161\/CIRCEP.114.002310","article-title":"Core isolation of critical arrhythmia elements for treatment of multiple scar-based ventricular tachycardias","volume":"8","author":"Tzou","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib60","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1540-8167.2011.02246.x","article-title":"Late potentials abolition as an additional technique for reduction of arrhythmia recurrence in scar related ventricular tachycardia ablation","volume":"23","author":"Vergara","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib61","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.hrthm.2017.05.018","article-title":"Cardiac magnetic resonance\u2013aided scar dechanneling: Influence on acute and long-term outcomes","volume":"14","author":"Andreu","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.08.007_bib62","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.jacc.2015.02.058","article-title":"Predictive value of programmed ventricular stimulation after catheter ablation of post-infarction ventricular tachycardia","volume":"65","author":"Yokokawa","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib63","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/01.CIR.0000027564.55739.B1","article-title":"Mapping and ablation of idiopathic ventricular fibrillation","volume":"106","author":"Ha\u00efssaguerre","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.08.007_bib64","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jacc.2009.03.065","article-title":"Long-term follow-up of idiopathic ventricular fibrillation ablation: a multicenter study","volume":"54","author":"Knecht","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib65","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1016\/j.jacc.2017.10.030","article-title":"Catheter ablation of ventricular tachycardia in structural heart disease","volume":"70","author":"Dukkipati","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib66","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacep.2018.06.014","article-title":"Ventricular tachycardia ablation in nonischemic cardiomyopathy","volume":"4","author":"Zeppenfeld","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib67","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.jacep.2019.09.015","article-title":"Ventricular tachycardia ablation","volume":"5","author":"Guandalini","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib68","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/CIRCULATIONAHA.113.003063","article-title":"Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study","volume":"129","author":"Dinov","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.08.007_bib69","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/europace\/euu326","article-title":"Substrate-guided ablation of haemodynamically tolerated and untolerated ventricular tachycardia in patients with structural heart disease: effect of cardiomyopathy type and acute success on long-term outcome","volume":"17","author":"Proietti","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2021.08.007_bib70","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jacep.2018.05.007","article-title":"Outcomes of catheter ablation of ventricular tachycardia based on etiology in nonischemic heart disease: an International Ventricular Tachycardia Ablation Center collaborative study","volume":"4","author":"Vaseghi","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib71","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jacc.2019.12.044","article-title":"Simultaneous endocardial and epicardial delineation of 3D reentrant ventricular tachycardia","volume":"75","author":"Tung","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib72","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007249","article-title":"Comparison of the ventricular tachycardia circuit between patients with ischemic and nonischemic cardiomyopathies: detailed characterization by entrainment","volume":"12","author":"Shirai","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib73","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1540-8167.1998.tb00907.x","article-title":"Endocardial and epicardial ablation guided by nonsurgical transthoracic epicardial mapping to treat recurrent ventricular tachycardia","volume":"9","author":"Sosa","year":"1998","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib74","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/CIRCEP.115.003562","article-title":"Long-term outcome with catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"8","author":"Santangeli","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib75","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.jacc.2016.08.058","article-title":"Long-term arrhythmic and nonarrhythmic outcomes of lamin A\/C mutation carriers","volume":"68","author":"Kumar","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib76","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jacep.2020.07.023","article-title":"Intramural venous ethanol infusion for refractory ventricular arrhythmias: outcomes of a multicenter experience","volume":"6","author":"Tavares","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib77","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1161\/CIRCEP.111.966283","article-title":"Transcoronary ethanol ablation for recurrent ventricular tachycardia after failed catheter ablation: an update","volume":"4","author":"Tokuda","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib78","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.hrthm.2020.04.028","article-title":"Acute and long-term results of bipolar radiofrequency catheter ablation of refractory ventricular arrhythmias of deep intramural origin","volume":"17","author":"Igarashi","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.08.007_bib79","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jacep.2018.06.021","article-title":"Prospective multicenter experience with cooled radiofrequency ablation using high impedance irrigant to target deep myocardial substrate refractory to standard ablation","volume":"4","author":"Nguyen","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib80","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.jacc.2018.12.070","article-title":"Infusion needle radiofrequency ablation for treatment of refractory ventricular arrhythmias","volume":"73","author":"Stevenson","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib81","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/CIRCEP.111.962555","article-title":"Surgical ablation of refractory ventricular tachycardia in patients with nonischemic cardiomyopathy","volume":"4","author":"Anter","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib82","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1056\/NEJMoa1613773","article-title":"Noninvasive cardiac radiation for ablation of ventricular tachycardia","volume":"377","author":"Cuculich","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2021.08.007_bib83","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/europace\/euz133","article-title":"Stereotactic radiosurgery for ablation of ventricular tachycardia","volume":"21","author":"Neuwirth","year":"2019","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2021.08.007_bib84","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1056\/NEJMoa065457","article-title":"Prophylactic catheter ablation for the prevention of defibrillator therapy","volume":"357","author":"Reddy","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2021.08.007_bib85","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(09)61755-4","article-title":"Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial","volume":"375","author":"Kuck","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.hroo.2021.08.007_bib86","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/CIRCULATIONAHA.119.043400","article-title":"Preventive or deferred ablation of ventricular tachycardia in patients with ischemic cardiomyopathy and implantable defibrillator (BERLIN VT): a multicenter randomized trial","volume":"141","author":"Willems","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.08.007_bib87","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.hrthm.2015.05.036","article-title":"Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: an International VT Ablation Center Collaborative Group study","volume":"12","author":"Tung","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.08.007_bib88","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/jce.13324","article-title":"Stellate ganglion blockade for the treatment of refractory ventricular arrhythmias: a systematic review and meta-analysis","volume":"28","author":"Fudim","year":"2017","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib89","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007080","article-title":"Thoracic epidural anesthesia can be effective for the short-term management of ventricular tachycardia storm","volume":"6","author":"Do","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hroo.2021.08.007_bib90","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1016\/j.jacc.2017.04.035","article-title":"Cardiac sympathetic denervation for refractory ventricular arrhythmias","volume":"69","author":"Vaseghi","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib91","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0025-6196(11)63724-5","article-title":"Suppression of frequent premature ventricular contractions and improvement of left ventricular function in patients with presumed idiopathic dilated cardiomyopathy","volume":"73","author":"Duffee","year":"1998","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.hroo.2021.08.007_bib92","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1016\/j.jacc.2018.09.059","article-title":"Left ventricular dyssynchrony predicts the cardiomyopathy associated with premature ventricular contractions","volume":"72","author":"Walters","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib93","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.hrthm.2010.03.036","article-title":"Relationship between burden of premature ventricular complexes and left ventricular function","volume":"7","author":"Baman","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.08.007_bib94","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.hrthm.2011.04.026","article-title":"Reversal of outflow tract ventricular premature depolarization\u2013induced cardiomyopathy with ablation: effect of residual arrhythmia burden and preexisting cardiomyopathy on outcome","volume":"8","author":"Mountantonakis","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.08.007_bib95","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.hrthm.2012.05.019","article-title":"Predictors of recovery of left ventricular dysfunction after ablation of frequent ventricular premature depolarizations","volume":"9","author":"Deyell","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.08.007_bib96","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.hrthm.2017.07.025","article-title":"Clinical recognition of pure premature ventricular complex-induced cardiomyopathy at presentation","volume":"14","author":"Penela","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.08.007_bib97","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.hrthm.2017.06.040","article-title":"Value of cardiac magnetic resonance imaging and programmed ventricular stimulation in patients with frequent premature ventricular complexes undergoing radiofrequency ablation","volume":"14","author":"Yokokawa","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.08.007_bib98","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jacc.2012.02.052","article-title":"Multifocal ectopic Purkinje-related premature contractions: a new SCN5A-related cardiac channelopathy","volume":"60","author":"Laurent","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib99","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.hrthm.2014.12.009","article-title":"Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen-Tawil syndrome with KCNJ2 mutations","volume":"12","author":"Miyamoto","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.08.007_bib100","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/europace\/euaa232","article-title":"Management of ventricular electrical storm: a contemporary appraisal","volume":"22","author":"Kowlgi","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2021.08.007_bib101","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/europace\/eut304","article-title":"Role of electrical storm as a mortality and morbidity risk factor and its clinical predictors: a meta-analysis","volume":"16","author":"Guerra","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2021.08.007_bib102","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijcard.2017.11.077","article-title":"Significant impact of electrical storm on mortality in patients with structural heart disease and an implantable cardiac defibrillator","volume":"255","author":"Noda","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib103","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.hrthm.2017.08.022","article-title":"Successful ventricular tachycardia ablation in patients with electrical storm reduces recurrences and improves survival","volume":"15","author":"Vergara","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.08.007_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171830","article-title":"Outcomes of ventricular tachycardia ablation in patients with structural heart disease: the impact of electrical storm","volume":"12","author":"Aldhoon","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.hroo.2021.08.007_bib105","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.hrthm.2018.04.028","article-title":"Outcomes with prophylactic use of percutaneous left ventricular assist devices in high-risk patients undergoing catheter ablation of scar-related ventricular tachycardia: a propensity-score matched analysis","volume":"15","author":"Muser","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.08.007_bib106","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10840-016-0168-8","article-title":"Outcomes of pre-emptive and rescue use of percutaneous left ventricular assist device in patients with structural heart disease undergoing catheter ablation of ventricular tachycardia","volume":"48","author":"Mathuria","year":"2017","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib107","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ijcard.2020.03.045","article-title":"Mechanical circulatory support for life-threatening arrhythmia: a systematic review","volume":"308","author":"Mariani","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib108","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/jce.13907","article-title":"Percutaneous left ventricular assist device support during ablation of ventricular tachycardia: a meta-analysis of current evidence","volume":"30","author":"Luni","year":"2019","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib109","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10840-018-0477-1","article-title":"Percutaneous ventricular assist device in ventricular tachycardia ablation: a systematic review and meta-analysis","volume":"55","author":"Turagam","year":"2019","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib110","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.006730","article-title":"Predictive score for identifying survival and recurrence risk profiles in patients undergoing ventricular tachycardia ablation: the I-VT score","volume":"11","author":"Vergara","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib111","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/ejhf.1568","article-title":"Cardiac implantable electronic devices with a defibrillator component and all-cause mortality in left ventricular assist device carriers: results from the PCHF-VAD registry","volume":"21","author":"Cikes","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hroo.2021.08.007_bib112","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.amjcard.2015.07.065","article-title":"Meta-analysis of the relation of ventricular arrhythmias to all-cause mortality after implantation of a left ventricular assist device","volume":"116","author":"Makki","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hroo.2021.08.007_bib113","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jacep.2018.05.006","article-title":"Predictors and clinical impact of late ventricular arrhythmias in patients with continuous-flow left ventricular assist devices","volume":"4","author":"Galand","year":"2018","journal-title":"JACC Clin Electrophysiol"}],"container-title":["Heart Rhythm O2"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666501821001616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666501821001616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:27:38Z","timestamp":1762993658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666501821001616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":113,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2666501821001616"],"URL":"https:\/\/doi.org\/10.1016\/j.hroo.2021.08.007","relation":{},"ISSN":["2666-5018"],"issn-type":[{"value":"2666-5018","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of ventricular arrhythmias in heart failure: Current perspectives","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm O2","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hroo.2021.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Heart Rhythm Society. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}